Access to highly active antiretroviral therapy (HAART) for women and children in the WHO European Region 2002-2006

By Stengaard Annemarie Rinder   Lazarus Jeffrey   Donoghoe Martin   Nielsen Stine   Matic Srdan  

AIDS Care, Vol. 21, Iss. 7, 2009-07 ,pp. : 893-902

Routledge Ltd

Access to resources Recommend Favorite

Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil

By Remien R. H.   Bastos F. I.   Jnr V. Terto   Raxach J. C.   Pinto R. M.   Parker R. G.   Berkman A.   Hacker M. A.  

AIDS Care, Vol. 19, Iss. 6, 2007-07 ,pp. : 740-748

Routledge Ltd

Access to resources Recommend Favorite

Rapid efficacy of highly active antiretroviral therapy in a case of HIV myelitis

By Michou L.   Sauve C.   Sereni C.   Lamotte C.   Maillard A.   Sereni D.  

European Journal of Internal Medicine, Vol. 13, Iss. 1, 2002-02 ,pp. : 65-66

Elsevier

Access to resources Recommend Favorite

Correlates of highly active antiretroviral therapy adherence among urban Ethiopian clients

By Alemu Hibret   Haile Mariam Damen   Tsui Amy O   Shewamare Aster  

African Journal of AIDS Research, Vol. 10, Iss. 3, 2011-09 ,pp. : 263-270

Routledge Ltd

Access to resources Recommend Favorite

Cardiovascular Toxicity With Highly Active Antiretroviral Therapy: Review of Clinical Studies

By Bozkurt Biykem  

Cardiovascular Toxicology, Vol. 4, Iss. 3, 2004-08 ,pp. : 243-260

Humana Press, Inc

Access to resources Recommend Favorite